Citoxlab acquires Xenometrics
An American CRO specialized in preclinical assessment of new drug candidates
Citoxlab Group, a leading player among non-clinical CROs, announces the acquisition of Xenometrics, an American CRO specialized in the non-clinical assessment of new drug candidates.
Webinar : Next generation of cardiac and CNS in vitro drug safety testing
January 31, 2018
Don’t miss our free live webinar with Dr Michael Accardi, Dr Hai Huang and Dr Simon Authier
For more information and registration click here.
CNS Safety Pharmacology
Discover EEG as a powerful neurological readout with established translational applications:
Continuous video-EEG, electro-oculogram, electromyogram, telemetry in conscious models, seizure liability, etc.
Dermal drug and skincare products
25-years of dedicated experience
From preclinical to clinical phase III development: Wound healing efficacy models, early screening, skin sensitization, 3D skin models, etc.
Prepare your regulatory submissions
Discover our customized packages and benefit from our unique expertise in nose-only and oro-nasal exposure.
Discover our growing portfolio of more than 200 biomarkers
Explore our translational science expertise through highly relevant preclinical and clinical biomarkers platforms.
Find out more: ELISA, ELISPOT, Functional assays, Flow cytometry and activation testing, Multiplex analysis, qPCR, genomics, etc.